MannKind Corporation (MNKD) Event May 12, 2022, 21:12 UTC (99% Neutral) MannKind Corporation (MNKD) Announces Regulatory Update Full text
Register to leave comments News bot Oct. 1, 2025, 7:46 p.m. 📋 MannKind Corporation (MNKD) - Regulatory Update Filing Date: 2022-05-12 Accepted: 2022-05-12 17:12:19 Event Type: Regulatory Update Event Details: MannKind Corporation (MNKD) Announces Regulatory Update MannKind Corporation (MNKD) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 🔬 Clinical Development Pipeline (MannKind Corporation): Product Type Development Stage Therapeutic Area Source Placebo DRUG Phase PHASE3 MAC Lung Disease ClinicalTrials.gov Clofazimine Inhalation Suspension DRUG Phase PHASE3 MAC Lung Disease ClinicalTrials.gov Control IQ + sleep activity with TI DEVICE Approved Diabetes Mellitus, Type 1 ClinicalTrials.gov PSMA/PRAME BIOLOGICAL Phase PHASE1 Ovarian ClinicalTrials.gov Biological: MKCC1106-MT BIOLOGICAL Phase PHASE1 Advanced Melanoma ClinicalTrials.gov Biological: MKC1106-MT BIOLOGICAL Phase PHASE1 Advanced Melanoma ClinicalTrials.gov Technosphere Insulin DRUG Phase PHASE2 Diabetes Mellitus, Type 1 ClinicalTrials.gov Technosphere/Insulin DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov Technosphere Insulin Inhalation Powder DRUG Phase PHASE2 Diabetes Type 2 ClinicalTrials.gov Fluticasone DRUG Phase PHASE1 Diabetes Mellitus ClinicalTrials.gov Albuterol (Salbutamol) DRUG Phase PHASE1 Diabetes Mellitus ClinicalTrials.gov Technosphere Insulin (TI) Inhalation Powder DRUG Phase PHASE1 Diabetes Mellitus ClinicalTrials.gov Technosphere Inhalation Powder DRUG Phase PHASE1 Mild Nephropathy ClinicalTrials.gov Actrapid DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov TI Inhalation Powder DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov Regular human insulin DRUG Phase PHASE1 Healthy ClinicalTrials.gov Technosphere® Insulin Inhalation Powder DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov Methacholine chloride DRUG Phase PHASE1 Asthma ClinicalTrials.gov Salbutamol (Albuterol) DRUG Phase PHASE1 Asthma ClinicalTrials.gov Technosphere Placebo DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov MKC253 Inhalation Powder DRUG Phase PHASE1 Diabetes Mellitus, Type 2 ClinicalTrials.gov Synchrotope TA2M BIOLOGICAL Phase PHASE1 Melanoma (Skin) ClinicalTrials.gov Technosphere Insulin Inhalation Powder using the Gen2C inhaler DRUG Phase PHASE1 Healthy ClinicalTrials.gov Comparator administered in parent trial DRUG Preclinical Type 1 Diabetes Mellitus ClinicalTrials.gov MKC1106-MT BIOLOGICAL Phase PHASE2 Stage III Melanoma ClinicalTrials.gov Technosphere Inhalation Powder (FDKP) DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov Moxifloxacin DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov Rapid Acting Analog DRUG Phase PHASE1 Type 1 Diabetes Mellitus ClinicalTrials.gov Technosphere®/Insulin DRUG Phase PHASE1 Chronic Obstructive Pulmonary Disease (COPD) ClinicalTrials.gov subcutaneous injection DRUG Phase PHASE1 Diabetes Mellitus, Type 2 ClinicalTrials.gov Technosphere® Insulin 30U DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov Technosphere® Insulin 10U + 20U DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov TI-Inhalation Powder B DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov TI-Inhalation Powder A DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov 70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin) DRUG Phase PHASE3 Diabetes Type 2 ClinicalTrials.gov Active comparator DRUG Phase PHASE3 Diabetes, Type I ClinicalTrials.gov Technosphere Insulin & Metformin DRUG Phase PHASE3 Diabetes Mellitus, Type 2 ClinicalTrials.gov Metformin & Secretagogues DRUG Phase PHASE3 Diabetes Mellitus, Type 2 ClinicalTrials.gov Technosphere® Insulin Inhalation System DRUG Approved Diabetes ClinicalTrials.gov Technosphere® Insulin Inhalation Powder and MedTone™ Inhaler DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov Usual Care DRUG Phase PHASE3 Diabetes, Type 1 ClinicalTrials.gov Insulin Aspart in combination with a basal insulin DRUG Phase PHASE3 Type 1 Diabetes Mellitus ClinicalTrials.gov Technosphere ®Insulin with Gen2 Inhaler DRUG Phase PHASE3 Type 1 Diabetes Mellitus ClinicalTrials.gov Technosphere® Insulin with MedTone C Inhaler DRUG Phase PHASE3 Type 1 Diabetes Mellitus ClinicalTrials.gov RAA Population DRUG Phase PHASE2 Diabetes Mellitus: Type 1 ClinicalTrials.gov Technosphere Insulin® Inhalation Powder DRUG Phase PHASE2 Diabetes Mellitus: Type 1 ClinicalTrials.gov Technosphere Powder DRUG Phase PHASE3 Type 2 Diabetes ClinicalTrials.gov Technosphere® Insulin DRUG Phase PHASE3 Type 2 Diabetes ClinicalTrials.gov Comparator DRUG Preclinical Type 1 Diabetes ClinicalTrials.gov Insulin lispro DRUG Phase PHASE3 Diabetes, Type 1 ClinicalTrials.gov Insulin glargine DRUG Phase PHASE3 Diabetes, Type 1 ClinicalTrials.gov TI Inhalation Powder (original protocol) DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov TI Inhalation Powder and Humalog (Amendment 1) DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov Insulin Aspart DRUG Phase PHASE3 Type 2 Diabetes ClinicalTrials.gov SAR439065 DRUG Phase PHASE1 Type 1 Diabetes Mellitus ClinicalTrials.gov Treprostinil Inhalation Powder DRUG Phase PHASE1 Pulmonary Arterial Hypertension ClinicalTrials.gov Technosphere Insulin SAR439065 Afrezza® DRUG Phase PHASE1 Type 1 Diabetes Mellitus ClinicalTrials.gov Afrezza Inhalant Product DRUG Phase PHASE4 Type 2 Diabetes Treated With Insulin ClinicalTrials.gov One Drop | Premium OTHER Phase PHASE4 Diabetes Mellitus, Type 2 ClinicalTrials.gov Afrezza plus One Drop | Premium DRUG Phase PHASE4 Diabetes Mellitus, Type 2 ClinicalTrials.gov Afrezza BIOLOGICAL Phase PHASE2 Type 1 Diabetes Mellitus ClinicalTrials.gov (Part B) MKND-201 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov (Part A) MKND-201 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov Basal Insulin BIOLOGICAL Phase PHASE4 Diabetes Mellitus, Type 1 ClinicalTrials.gov Rapid-acting Insulin Analog BIOLOGICAL Phase PHASE4 Diabetes Mellitus, Type 1 ClinicalTrials.gov insulin degludec BIOLOGICAL Phase PHASE4 Diabetes Mellitus, Type 1 ClinicalTrials.gov Continuous Subcutaneous Insulin Infusion (CSII) pump with Automatic Insulin Delivery (AID) DEVICE Phase PHASE4 Type 1 Diabetes ClinicalTrials.gov Afrezza (insulin human) Inhalation Powder BIOLOGICAL Phase PHASE4 Type 1 Diabetes ClinicalTrials.gov Inhaled Technosphere Insulin DRUG Phase PHASE2 Diabetes, Gestational ClinicalTrials.gov 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: MannKind CorporationCIK: 0000899460Ticker Symbol: MNKDPeriod End Date: 2022-05-10Document Type: 8-K
📋 MannKind Corporation (MNKD) - Regulatory Update
Filing Date: 2022-05-12
Accepted: 2022-05-12 17:12:19
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (MannKind Corporation):
💼 Business Developments:
Structured Data: